Skip to main content
Clinical Trials/EUCTR2009-011599-31-AT
EUCTR2009-011599-31-AT
Active, not recruiting
Phase 1

The effect of high-dose remifentanil on the reversal of established capsaicin-induced hyperalgesia in human volunteers

Abteilung für Anaesthesie und Intensivmedizin, Medizinische Universität Wien0 sitesApril 21, 2009

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
This is a volunteer study in healthy volunteers. Pain research, reversal of hyperalgesia by IMP ist studied
Sponsor
Abteilung für Anaesthesie und Intensivmedizin, Medizinische Universität Wien
Status
Active, not recruiting
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 21, 2009
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Abteilung für Anaesthesie und Intensivmedizin, Medizinische Universität Wien

Eligibility Criteria

Inclusion Criteria

  • Men or women, aged between 19 and 40 years
  • Body mass index between 15th and 85th percentile
  • Normal findings in the medical history and physical examination
  • Drug free for 1 week prior to the study day
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Any of the following will exclude a subject from the study:
  • Regular use of medication especially analgesics,
  • Abuse of alcoholic beverages, drug abuse
  • History of asthma
  • Participation in a clinical trial in the 2 weeks preceding the study
  • Symptoms of a clinically relevant illness in the 2 weeks before the first study day
  • Resting systolic blood pressure \>135 mmHg or diastolic blood pressure \>85 mmHg
  • Pregnancy or breast feeding

Outcomes

Primary Outcomes

Not specified

Similar Trials